Skip to main content
. Author manuscript; available in PMC: 2015 Mar 17.
Published in final edited form as: Curr Protoc Pharmacol. 2013 Oct 8;62:Unit–14.27.. doi: 10.1002/0471141755.ph1427s62

Figure 14.27.3.

Figure 14.27.3

Preclinical testing of Auranofin (AFN) in lung orthotopic tumors. (A) Lateral view of representative bioluminescent images of control and AFN-treated mice bearing lung orthotopic tumors of H1703/Luc cells at 14 days after implantation. (B) Lateral view of bioluminescent images of a mouse bearing lung orthotopic tumors of H1703/Luc cells at 14 days after start of treatment. (C) Quantitative analysis of luciferase bioluminescence images taken at the indicated time points after inoculation. Data are the mean total bioluminescence flux (photons/sec).